|
|
妊娠合并弥漫大B细胞淋巴瘤和噬血细胞综合征1例并文献复习
|
Abstract:
目的：探讨妊娠合并弥漫大B细胞淋巴瘤、噬血细胞综合征患者的临床管理方法。方法：回顾性分析2024年10月19日青岛大学附属医院收治的1例孕31周1天合并弥漫大B细胞淋巴瘤、噬血细胞综合征患者的临床资料，并复习相关文献，分析诊疗策略。结果：患者经淋巴结穿刺活检明确诊断为淋巴瘤，诊断时患者处于孕晚期、淋巴瘤进展期，于孕33周3天经剖宫产终止妊娠，患者术后症状加重、病情进展，转入血液内科后于术后第9天给予减量R-CHOP方案化疗，化疗后出现噬血细胞综合征，转入重症医学科后给予甲泼尼龙、美罗培南抗炎及对症治疗后病情稳定，术后新生儿经积极救治后康复出院。结论：妊娠合并淋巴瘤、噬血细胞综合征的治疗应该是个体化的，需要综合考虑胎儿、母亲和疾病相关因素的影响，在挽救母体生命的同时减少对胎儿的影响，建立多学科团队有助于疑难病例的临床诊疗。
Objective: This study examined clinical management strategies for pregnant patients diagnosed with diffuse large B-cell lymphoma and hemophagocytic lymphohistiocytosis. Methods: A retrospective analysis was conducted on the clinical data of a 31-week-and-1-day pregnant patient diagnosed with DLBCL and HLH upon admission to the Affiliated Hospital of Qingdao University on October 19, 2024. Additionally, a comprehensive review of relevant literature was undertaken to evaluate diagnostic and therapeutic approaches. Results: The patient was diagnosed with lymphoma through a lymph node biopsy in the third trimester, revealing an advanced stage of the disease. Pregnancy termination was performed via cesarean section at 33 weeks and 3 days gestation. Postoperatively, the patient’s condition deteriorated, prompting a transfer to the Hematology Department, where a reduced-dose R-CHOP chemotherapy regimen was initiated on the 9th day post-operation. HLH subsequently developed following chemotherapy. After transfer to the Intensive Care Unit, methylprednisolone and meropenem were administered for anti-inflammatory and symptomatic treatment, stabilizing her condition. The neonate underwent successful treatment and was discharged postoperatively. Conclusion: Tailored treatment strategies are essential in managing pregnancies complicated by DLBCL and HLH. A thorough evaluation of fetal, maternal, and disease-related factors is critical to optimize maternal survival while minimizing fetal risks. The establishment of a multidisciplinary team is beneficial in managing the clinical complexities of such cases.
| [1] | Zayac, A.S., Egini, O., Palmisiano, N.D. and Evens, A.M. (2025) Lymphoma and Leukemia Occurring during Pregnancy. Seminars in Perinatology, 49, Article 152041. https://doi.org/10.1016/j.semperi.2025.152041 |
| [2] | Pirosa, M.C. and Peccatori, F.A. (2023) Lymphomas in Pregnancy. Hematological Oncology, 41, 70-74. https://doi.org/10.1002/hon.3150 |
| [3] | Di Ciaccio, P.R., Mills, G., Shipton, M.J., Campbell, B., Gregory, G., Langfield, J., et al. (2023) The Clinical Features, Management and Outcomes of Lymphoma in Pregnancy: A Multicentre Study by the Australasian Lymphoma Alliance. British Journal of Haematology, 201, 887-896. https://doi.org/10.1111/bjh.18727 |
| [4] | Ambrose Fistus, V., Sharief, M. and Sarma, A. (2025) Haemophagocytic Lymphohistiocytosis (HLH) with Concurrent Hodgkin’s Disease. BMJ Case Reports, 18, e261944. https://doi.org/10.1136/bcr-2024-261944 |
| [5] | Liu, L., Cui, Y., Zhou, Q., Zhao, H. and Li, X. (2021) Hemophagocytic Lymphohistiocytosis during Pregnancy: A Review of the Literature in Epidemiology, Pathogenesis, Diagnosis and Treatment. Orphanet Journal of Rare Diseases, 16, Article No. 281. https://doi.org/10.1186/s13023-021-01790-9 |
| [6] | Siddik, N.A., Abd Rahim, S.N.H., Jamaluddin, J. and Yuhana, M.Y. (2024) Hemophagocytic Lymphohistiocytosis Associated with T-Cell Lymphoma in Pregnancy: Diagnostic Conundrum Unveiled. Cureus, 16, e66170. https://doi.org/10.7759/cureus.66170 |
| [7] | 余琳, 洪凡, 陈敦金. 妊娠合并噬血细胞综合征[J]. 中国实用妇科与产科杂志, 2024, 40(12): 1186-1190. |
| [8] | 王绮, 付帅, 张蜀宁, 等. 孕中期合并淋巴瘤、噬血细胞综合征个案报道并文献复习[J]. 中国医刊, 2022, 57(2): 227-230. |
| [9] | Shah, M.R., Brandt, J.S., David, K.A. and Evens, A.M. (2020) Lymphoma Occurring during Pregnancy: Current Diagnostic and Therapeutic Approaches. Current Oncology Reports, 22, Article No. 113. https://doi.org/10.1007/s11912-020-00972-1 |
| [10] | Pinson, P., Boussaid, I., Decroocq, J., Chouchana, L., Birsen, G., Barrois, M., et al. (2024) Maternal and Obstetric Outcomes in Women with Pregnancy-Associated Haematological Malignancies: An Observational Nationwide Cohort Study. The Lancet Haematology, 11, e850-e861. https://doi.org/10.1016/s2352-3026(24)00288-6 |
| [11] | Gurevich-Shapiro, A. and Avivi, I. (2019) Current Treatment of Lymphoma in Pregnancy. Expert Review of Hematology, 12, 449-459. https://doi.org/10.1080/17474086.2019.1615878 |
| [12] | Avivi, I., Farbstein, D., Brenner, B. and Horowitz, N.A. (2014) Non-Hodgkin Lymphomas in Pregnancy: Tackling Therapeutic Quandaries. Blood Reviews, 28, 213-220. https://doi.org/10.1016/j.blre.2014.06.004 |
| [13] | Pinnix, C.C., Andraos, T.Y., Milgrom, S. and Fanale, M.A. (2017) The Management of Lymphoma in the Setting of Pregnancy. Current Hematologic Malignancy Reports, 12, 251-256. https://doi.org/10.1007/s11899-017-0386-x |
| [14] | Amant, F., Verheecke, M., Wlodarska, I., Dehaspe, L., Brady, P., Brison, N., et al. (2015) Presymptomatic Identification of Cancers in Pregnant Women during Noninvasive Prenatal Testing. JAMA Oncology, 1, Article 814. https://doi.org/10.1001/jamaoncol.2015.1883 |
| [15] | Mills, G.S., Chadwick, V., Tang, C., Perram, J., Anderson, M.A., Anazodo, A., et al. (2023) Immunochemotherapy for Life-Threatening Haematological Malignancies in Pregnancy: A Systematic Review of the Literature and Cross-Sectional Analysis of Clinical Trial Eligibility. The Lancet Haematology, 10, e458-e467. https://doi.org/10.1016/s2352-3026(23)00059-5 |
| [16] | Pinnix, C.C., Osborne, E.M., Chihara, D., Lai, P., Zhou, S., Ramirez, M.M., et al. (2016) Maternal and Fetal Outcomes after Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed during Pregnancy. JAMA Oncology, 2, Article 1065. https://doi.org/10.1001/jamaoncol.2016.1396 |
| [17] | Maggen, C., Dierickx, D., Cardonick, E., Mhallem Gziri, M., Cabrera‐Garcia, A., Shmakov, R.G., et al. (2021) Maternal and Neonatal Outcomes in 80 Patients Diagnosed with Non‐Hodgkin Lymphoma during Pregnancy: Results from the International Network of Cancer, Infertility and Pregnancy. British Journal of Haematology, 193, 52-62. https://doi.org/10.1111/bjh.17103 |
| [18] | Das, G., Damotte, V., Gelfand, J.M., Bevan, C., Cree, B.A.C., Do, L., et al. (2018) Rituximab before and during Pregnancy. Neurology Neuroimmunology & Neuroinflammation, 5, e453. https://doi.org/10.1212/nxi.0000000000000453 |
| [19] | Annunzio, K., Cackovic, M., Bond, D., Sawalha, Y., Voorhees, T.J., Hanel, W., et al. (2023) Treatment of Primary Mediastinal B-Cell Lymphoma with Dose-Adjusted REPOCH during Pregnancy. Blood Advances, 7, 2241-2244. https://doi.org/10.1182/bloodadvances.2022008621 |
| [20] | Odelia, A., Erel, J., Chava, P., Yair, H., Nadav, S., Michael, L., et al. (2016) Continuing Dilemmas in the Management of Lymphoma during Pregnancy: Review of a 10-Point Case-Based Questionnaire. International Journal of Clinical Oncology, 22, 190-199. https://doi.org/10.1007/s10147-016-1036-3 |
| [21] | Amant, F., Vandenbroucke, T., Verheecke, M., Fumagalli, M., Halaska, M.J., Boere, I., et al. (2015) Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. New England Journal of Medicine, 373, 1824-1834. https://doi.org/10.1056/nejmoa1508913 |
| [22] | Amit, O., Barzilai, M. and Avivi, I. (2015) Management of Hematologic Malignancies: Special Considerations in Pregnant Women. Drugs, 75, 1725-1738. https://doi.org/10.1007/s40265-015-0464-0 |
